Pharma
Merck execs say they expect a $200m hit from Trump tariffs
Pharma companies are highlighting their US investments as the government threatens pharmaceutical tariffs.
Sponsored by Pri-MedHealthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.